SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-22-030726
Filing Date
2022-08-24
Accepted
2022-08-24 16:03:11
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 ny20005031x1_s3.htm S-3 495983
2 EXHIBIT 1.2 ny20005031x1_ex1-2.htm EX-1.2 312849
3 EXHIBIT 4.3 ny20005031x1_ex4-3.htm EX-4.3 452864
4 EXHIBIT 5.1 ny20005031x1_ex5-1.htm EX-5.1 36249
5 EXHIBIT 5.2 ny20005031x1_ex5-2.htm EX-5.2 6823
6 EXHIBIT 23.1 ny20005031x1_ex23-1.htm EX-23.1 1542
7 FILING FEES TABLE ny20005031x1_ex107.htm EX-FILING FEES 51931
8 logo_pdsbiotech.jpg GRAPHIC 36439
  Complete submission text file 0001140361-22-030726.txt   1409350
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267041 | Film No.: 221191544
SIC: 2834 Pharmaceutical Preparations